Clinical trials
Phase 1 Lung Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 6 |
| 2022 | 5 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 6 |
| Active, not recruiting | 5 |
| Completed | 5 |
| Recruiting | 5 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Blueprint Medicines Corporation | 2 |
| Eli Lilly and Company | 2 |
| Turning Point Therapeutics, Inc. | 2 |
| Wellmarker Bio | 2 |
| Amgen | 1 |
| AstraZeneca | 1 |
| BeOne Medicines | 1 |
| IDEAYA Biosciences | 1 |
| Korea University Guro Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 24 |
| Carcinoma, Non-Small-Cell Lung | 16 |
| Neoplasms | 8 |
| Colorectal Neoplasms | 7 |
| Neoplasm Metastasis | 7 |
| Pancreatic Neoplasms | 5 |
| Head and Neck Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Adenocarcinoma | 3 |
| Breast Neoplasms | 3 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.